Literature DB >> 1317517

Functional endothelin 1 receptors on human glomerular podocytes and mesangial cells.

J M Rebibou1, C J He, F Delarue, M N Peraldi, C Adida, E Rondeau, J D Sraer.   

Abstract

To determine if endothelin 1 (Et1) receptors are present in human glomeruli, and which glomerular cells possess these receptors, 125I Et1 binding to isolated glomeruli and cultured glomerular mesangial and epithelial cells was studied. The latter were identified as podocytes. We demonstrated that Et1 binds specifically and reversibly to isolated human glomeruli and to cultured glomerular mesangial and epithelial cells. Scatchard analysis of competitive inhibition of 125I Et1 binding gave the following results (m +/- SEM, n = 3): isolated glomeruli, Kd = 4.2 +/- 2.1 x 10(-10) M, Bmax = 8.1 +/- 1.2 x 10(10) sites/mg protein; mesangial cells, Kd = 5.2 +/- 1.5 x 10(-10) M, Bmax = 1.87 +/- 0.49 x 10(4) sites/cell; epithelial cells, Kd = 7.2 +/- 1.5 x 10(-10) M, Bmax = 2.46 +/- 0.15 x 10(4) sites/cell. These receptors seem to be functional, since in both mesangial and epithelial cells Et1 induces a rapid and transient increase in intracellular [Ca2+]i. All these results indicate that Et1 may regulate glomerular filtration rate through an autocrine-paracrine pathway on mesangial cells and on podocytes.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1317517     DOI: 10.1093/oxfordjournals.ndt.a092130

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  14 in total

Review 1.  Physiology of endothelin and the kidney.

Authors:  Donald E Kohan; Edward W Inscho; Donald Wesson; David M Pollock
Journal:  Compr Physiol       Date:  2011-04       Impact factor: 9.090

2.  [125I]-PD151242: a selective ligand for endothelin ETA receptors in human kidney which localizes to renal vasculature.

Authors:  A P Davenport; R E Kuc; S L Hoskins; F E Karet; F Fitzgerald
Journal:  Br J Pharmacol       Date:  1994-12       Impact factor: 8.739

Review 3.  Regulation of blood pressure and salt homeostasis by endothelin.

Authors:  Donald E Kohan; Noreen F Rossi; Edward W Inscho; David M Pollock
Journal:  Physiol Rev       Date:  2011-01       Impact factor: 37.312

4.  Angiotensin II depolarizes podocytes in the intact glomerulus of the Rat.

Authors:  J Gloy; A Henger; K G Fischer; R Nitschke; P Mundel; M Bleich; P Schollmeyer; R Greger; H Pavenstädt
Journal:  J Clin Invest       Date:  1997-06-01       Impact factor: 14.808

5.  Endothelin receptor A-specific stimulation of glomerular inflammation and injury in a streptozotocin-induced rat model of diabetes.

Authors:  M A Saleh; E I Boesen; J S Pollock; V J Savin; D M Pollock
Journal:  Diabetologia       Date:  2010-12-30       Impact factor: 10.122

Review 6.  Endothelin and the glomerulus in chronic kidney disease.

Authors:  Matthias Barton; Andrey Sorokin
Journal:  Semin Nephrol       Date:  2015-03       Impact factor: 5.299

Review 7.  Endothelin-1 and the kidney--beyond BP.

Authors:  Neeraj Dhaun; David J Webb; David C Kluth
Journal:  Br J Pharmacol       Date:  2012-10       Impact factor: 8.739

Review 8.  Endothelin antagonists for diabetic and non-diabetic chronic kidney disease.

Authors:  Donald E Kohan; David M Pollock
Journal:  Br J Clin Pharmacol       Date:  2013-10       Impact factor: 4.335

9.  Vascular Endothelial Growth Factor and Podocyte Protection in Chronic Hypoxia: Effects of Endothelin-A Receptor Antagonism.

Authors:  Taylor W Harvey; Jason E Engel; Alejandro R Chade
Journal:  Am J Nephrol       Date:  2016-03-02       Impact factor: 3.754

10.  ACE-inhibitors but not endothelin receptor blockers prevent podocyte loss in early diabetic nephropathy.

Authors:  M-L Gross; A El-Shakmak; A Szábó; A Koch; A Kuhlmann; K Münter; E Ritz; K Amann
Journal:  Diabetologia       Date:  2003-06-11       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.